Predictive Factors and Autonomy Level Change

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorHospices Civils de Lyon

About this trial

The Alzheimer's disease or related disorders (ADRD) are among the most disabling diseases because of their main features such as cognitive impairment, loss of functional autonomy and behavioural disorders. In absence of current curative treatment, the identification of the predictive risk factors of progression of the disease, evaluated through its main symptoms, represents a major stake of public health. The investigators aimed at developing a database, which includes the patient medical records on a prospective basis, in collaboration with the medical and administrative personal and with the University hospital computer science department. The main objective is to study the predictive factors associated with the change of functional autonomy level, measured every 6 months to 12 months by phone, in a Memory Clinic. The study population would consist in about 1000 patients with ADRD. The length of follow-up of each patient will be 3 years.

Eligibility criteria

Qualifiers

Patients who undergo a medical visit in the Memory Clinic for the 1st time

Patients living at home or in housing

Patients with memory impairment, at all stage of the disease

Disqualifiers

Patients in institution

Patients under legal protection

Patients with a hearing or visual impairment, which dot not allow to carry out the examination

Trial design

Treatments tested in this trial

  • The Lawton Instrumental Activities of Daily Living score (IADL), and the disability assessment of dementia score (DAD-6

Treatment groups

10,860 Participants
are divided into 1 treatment group

Sponsors and collaborators